Researchers of the Josep Carreras Leukaemia Research Institute discover that a leukaemic cell is capable of transforming into a non-cancerous cell through epigenetic changes.
Nov 13, 2019
0
2
Ruth M. Risueño leads the Leukaemic Stem Cell group of the Josep Carreras Leukaemia Research Institute. This group investigates Acute Myeloid Leukaemia (AML) and the cell population responsible for the disease spreading, ...
Sep 6, 2019
0
6
T-cell ProLymphocytic leukemia (T-PLL) is the most aggressive of all known forms of leukemia. Although many cancer drugs are now available, therapeutic success is limited for T-PLL patients. Until now, no international studies ...
Sep 2, 2019
0
3
Around 22,000 people will be diagnosed this year in the US with acute myeloid leukemia (AML), the second most common type of leukemia diagnosed in adults and children, and the most aggressive of the leukemias. Less than one ...
Aug 1, 2019
0
47
Researchers at the University of Birmingham have shown that it's possible to produce a compound with anti-cancer properties directly from feverfew—a common flowering garden plant.
Aug 1, 2019
0
4
Researchers at the University of Oxford, in collaboration with colleagues from Hannover Medical School and Martin-Luther-University Halle-Wittenberg, have discovered the specific gene mutations that are required for the development ...
Jul 11, 2019
0
0
Institute scientists have revealed that a gene called PHF6 plays a powerful role in protecting against blood cancer. The study showed how a breakdown in the gene's function could accelerate the development of T cell acute ...
Apr 30, 2019
0
3
The most common form of childhood cancer is acute lymphoblastic leukaemia (ALL). Researchers at Lund University in Sweden, in cooperation with Karolinska Institutet, SciLifeLab and the University of Cambridge, have now carried ...
Apr 26, 2019
0
9
New findings about a fatal form of blood cancer could aid the development of new drugs with significantly less harmful side effects than existing chemotherapy.
Apr 25, 2019
0
16
Genetic mutations that drive the development of a common type of childhood leukaemia can be traced back to errors by the immune system during the production of antibodies.
Mar 22, 2019
0
87
